IFP Advisors Inc cut its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 5.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,631 shares of the medical research company’s stock after selling 771 shares during the period. IFP Advisors Inc’s holdings in Thermo Fisher Scientific were worth $2,768,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of TMO. Proficio Capital Partners LLC grew its holdings in Thermo Fisher Scientific by 71.5% during the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after purchasing an additional 253 shares during the last quarter. Chicago Partners Investment Group LLC bought a new position in Thermo Fisher Scientific during the 2nd quarter valued at about $108,000. Cribstone Capital Management LLC grew its holdings in Thermo Fisher Scientific by 8.7% during the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 50 shares during the last quarter. Shine Investment Advisory Services Inc. bought a new position in Thermo Fisher Scientific during the 2nd quarter valued at about $113,000. Finally, Ropes Wealth Advisors LLC grew its holdings in Thermo Fisher Scientific by 15.8% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after purchasing an additional 97 shares during the last quarter. Hedge funds and other institutional investors own 85.32% of the company’s stock.

Several brokerages recently commented on TMO. Jefferies Group LLC reiterated a “hold” rating and set a $195.00 price target on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $197.00 price target on the stock in a report on Tuesday, August 1st. BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Goldman Sachs Group, Inc. (The) began coverage on shares of Thermo Fisher Scientific in a report on Tuesday, September 26th. They set a “buy” rating and a $225.00 price target on the stock. Finally, Barclays PLC reiterated an “overweight” rating and set a $215.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. One research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $205.71.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at $192.93 on Wednesday. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $201.20. The firm has a market cap of $76,590.12, a P/E ratio of 20.99, a PEG ratio of 1.75 and a beta of 1.08. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm had revenue of $5.12 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same quarter in the prior year, the company earned $2.03 EPS. The company’s revenue was up 13.9% compared to the same quarter last year. research analysts expect that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be given a $0.15 dividend. The ex-dividend date is Thursday, December 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.31%. Thermo Fisher Scientific’s payout ratio is presently 10.19%.

In other news, Director C Martin Harris sold 360 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the sale, the director now owns 5,312 shares of the company’s stock, valued at approximately $961,312.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Daniel P. Shine sold 2,026 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total transaction of $366,645.22. Following the completion of the sale, the insider now directly owns 20,682 shares of the company’s stock, valued at approximately $3,742,821.54. The disclosure for this sale can be found here. Insiders sold a total of 60,420 shares of company stock valued at $11,308,477 in the last ninety days. Corporate insiders own 0.49% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/ifp-advisors-inc-trims-stake-in-thermo-fisher-scientific-inc-tmo/1719219.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.